SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: SKYSTARMMENCES TESTING ON TWODITIONAL NEW PRODUCT DOSAGE FORMS

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 8-K, Date: 2010-05-12
Original SEC Filing: Click here


Webplus: SKBI/20100512/8-K/2_EX-99.1/000.htm SEC Original: v184608_ex99-1.htm
SKYSTARMMENCES TESTING ON TWODITIONAL NEW PRODUCT DOSAGE FORMS TO FURTHER EXPAND THEMPANYS PRODUCT LINES The new dosage forms projected to generate $5 million inditional revenue by fiscal 2011 XI’AN, CHINA May 12, 2010 -ystar Bio-Pharmaceuticalmpany (NASDAQ:SKBI) (“Skystar” or the “Company”), The product testing process will ensure that the new dosage forms willhere to good manufacturing




Webplus: SKBI/20100512/8-K/1/000.htm SEC Original: v184608_8k.htm
FORM 8-K CURRENT REPORTte of report (Date of earliest event reported): May 12, 2010YSTAR BIO-PHARMACEUTICALMPANY Nevada 001-34394 33-0901534 (State or other jurisdiction oforporation or organization) (Commission File No.) (IRS Employer Identification No.) Rm. 10601, Jiezuo Plaza, No.4, Fenghui Road South, Gaoxin District, Xian, Shaanxi Province, P.R. China



Company Information:

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 8-K, Date: 2010-05-12CIK: 0001076939, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
RM 10601, JIEZUO PLAZA, NO. 4, FENGHUI ROAD SOUTH, GAOXIN DISTRICT
XIAN PROVINCE

Home Page Forums

By | 2016-02-05T04:24:46+00:00 May 12th, 2010|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

About the Author:

Leave A Comment

Skip to toolbar